fda drug shortages semaglutide injection shortage resolved 2025 ends as sets deadline for compounders Shortage of popular weight-loss and
Description
The result should equal your target dose
The medication type wasnt named at checkout, only listed as GLP-1, and pricing required direct outreach instead of being clearly disclosed
Update on the evaluation of thyroid nodules
It is FDA-approved, widely available, and produces roughly 30-50% more weight loss than semaglutide in clinical trials
Up to this point, we may have been cautious about prescribing the oral preparation in this high-risk group
